Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

Erin R. Lepper, Sharyn D. Baker, Matt Permenter, Nicole Ries, Ron H.N. Van Schaik, Paul W. Schenk, Douglas K. Price, Danielle Ahn, Nicola F. Smith, George Cusatis, Roxann G. Ingersoll, Susan E. Bates, Ron H.J. Mathijssen, Jaap Verweij, William D. Figg, Alex Sparreboom*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences